David Westenberg is ranked #1678 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

David Westenberg (Piper Sandler) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are David Westenberg's stock ratings?

About 45% of David's ratings were profitable over a one-year hold, with an average return of +72.7% per rating, measured by 13Foresight from historical prices.

Analyst Tracker/David Westenberg

PIPR

David Westenberg

Piper Sandler

Wall Street Analyst

★★★☆☆

#1678

on 13Foresight · ranked by our own returns

45%

Success Rate

+72.7%

Average Return

15 of 33 calls profitable · +69.3% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 45% of David Westenberg's ratings turned a profit when each position was held for 1 year — averaging +72.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

86 Buy 52 Hold 0 Sell

David's Stock Coverage 39 ratings · 2026-06-19

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
A Agilent	Jun 11, 2026	HOLD	Strong Buy +3.9% avg upside 32 analysts	$150.00 18.05% Upside	·
TWST Twist Bioscience	Jun 11, 2026	BUY	Strong Buy -25.5% avg upside 14 analysts	$85.00 2.93% Downside	+14.7%
IT:DIA DiaSorin S.p.A.	Jun 11, 2026	HOLD	Hold +52.4% avg upside 9 analysts	$75.00 17.70% Upside	·
FR:BIM bioMerieux	Jun 11, 2026	HOLD	Buy +54.1% avg upside 12 analysts	$80.00 18.39% Upside	·
WAT Waters	Jun 11, 2026	HOLD	Strong Buy +3.5% avg upside 30 analysts	$400.00 12.49% Upside	-0.5%
TMO Thermo Fisher	Jun 11, 2026	HOLD	Strong Buy +26.9% avg upside 38 analysts	$510.00 9.87% Upside	-0.6%
TECH Bio-Techne	Jun 11, 2026	HOLD	Strong Buy +38.6% avg upside 21 analysts	$65.00 12.19% Upside	+3.7%
DHR Danaher	Jun 11, 2026	HOLD	Strong Buy +21.8% avg upside 45 analysts	$200.00 12.93% Upside	+0.3%
GRAL GRAIL Inc	Jun 02, 2026	HOLD	Buy +3.6% avg upside 8 analysts	$56.00 12.09% Downside	-2.7%
GH Guardant Health	May 28, 2026	BUY	Strong Buy -5.8% avg upside 30 analysts	$135.00 2.54% Upside	-2.5%
MYGN Myriad Genetics	May 12, 2026	BUY	Hold +315.3% avg upside 24 analysts	$8.50 87.28% Upside	-3.9%
CAI Caris Life Sciences, Inc.	May 12, 2026	HOLD	Strong Buy +54.5% avg upside 20 analysts	$21.00 13.65% Upside	-1.6%
TEM Tempus AI, Inc. Class A	May 12, 2026	HOLD	Strong Buy +33.8% avg upside 19 analysts	$58.00 13.99% Upside	+7.7%
ADPT Adaptive Biotechnologies	May 12, 2026	BUY	Strong Buy +20.0% avg upside 14 analysts	$20.00 14.17% Upside	+29.1%
NTRA Natera	May 12, 2026	BUY	Strong Buy +7.6% avg upside 26 analysts	$249.00 7.62% Upside	+10.9%
PACB Pacific Biosciences	May 08, 2026	HOLD	Buy +214.0% avg upside 14 analysts	$2.00 42.84% Upside	-20.6%
CTKB Cytek Biosciences	May 08, 2026	BUY	Buy +49.2% avg upside 5 analysts	$7.50 98.99% Upside	-9.1%
TXG 10x Genomics	May 08, 2026	HOLD	Buy -26.8% avg upside 18 analysts	$20.00 42.47% Downside	+47.0%
BLLN BillionToOne, Inc. Class A	May 07, 2026	BUY	Strong Buy +16.4% avg upside 8 analysts	$130.00 23.53% Upside	+8.8%
WGS GeneDx Holdings	May 05, 2026	BUY	Strong Buy +35.9% avg upside 9 analysts	$130.00 120.21% Upside	+77.7%
FLGT Fulgent Genetics	May 05, 2026	HOLD	Buy +143.4% avg upside 7 analysts	$15.00 16.58% Downside	+6.1%
TRUP Trupanion	May 01, 2026	BUY	Strong Buy +73.5% avg upside 19 analysts	$45.00 91.16% Upside	-2.1%
ILMN Illumina	May 01, 2026	BUY	Buy -10.0% avg upside 30 analysts	$170.00 5.03% Upside	+17.2%
NEO NeoGenomics	Apr 30, 2026	BUY	Strong Buy +40.2% avg upside 17 analysts	$13.00 16.72% Upside	+20.4%
LH Labcorp Holdings	Feb 24, 2026	HOLD	Strong Buy +1.8% avg upside 36 analysts	$300.00 17.18% Upside	-10.4%
IDXX Idexx Laboratories	Feb 09, 2026	HOLD	Buy +29.2% avg upside 17 analysts	$750.00 33.35% Upside	-12.3%
ZTS Zoetis	Jan 22, 2026	HOLD	Buy +71.4% avg upside 22 analysts	$135.00 71.61% Upside	-37.6%
ELAN Elanco Animal Health	Jan 22, 2026	BUY	Strong Buy +24.1% avg upside 18 analysts	$30.00 23.94% Upside	-2.7%
NEOG Neogen	Jan 12, 2026	HOLD	Buy +148.1% avg upside 6 analysts	$10.00 7.46% Upside	-7.3%
DGX Quest Diagnostics	Oct 27, 2025	HOLD	Buy -12.4% avg upside 33 analysts	$200.00 2.60% Upside	+10.7%
GB:ONT Oxford Nanopore Technologies PLC	Sep 03, 2025	BUY	Strong Buy +79.8% avg upside 6 analysts	$190.00 65.76% Upside	·
IMDX Insight Molecular Diagnostics	Nov 13, 2023	HOLD	Buy -0.6% avg upside 10 analysts	$3.00 44.85% Downside	·
RNLXY Renalytix	Oct 04, 2021	BUY	Strong Buy +800.3% avg upside 5 analysts	$28.00 2245.04% Upside	·
PAHC Phibro Animal Health	May 23, 2019	HOLD	Hold +17.0% avg upside 10 analysts	—	-15.2%
RGEN Repligen	Dec 17, 2018	BUY	Strong Buy +28.3% avg upside 25 analysts	$65.00 50.80% Downside	+2439.4%
PETS Petmed Express	Jun 15, 2018	HOLD	Sell +700.0% avg upside 6 analysts	—	-58.2%
BIO Bio-Rad Laboratories	Feb 16, 2018	HOLD	Buy +23.7% avg upside 8 analysts	—	·
QDEL QuidelOrtho	Jan 04, 2018	BUY	Buy +185.5% avg upside 13 analysts	$52.00 280.31% Upside	+6.8%
CENT Central Garden Pet	Dec 07, 2017	BUY	Buy +2.4% avg upside 9 analysts	$47.00 8.94% Upside	-18.5%

🔒 34 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

David Westenberg — Frequently Asked Questions

How accurate are David Westenberg's stock ratings?

Based on the calls 13Foresight could measure, about 45% of David's ratings were profitable over a one-year hold, with an average return of +72.7% per rating, or +69.3% versus the S&P 500. We score every analyst the same way, from historical prices.

How is David ranked on 13Foresight?

David Westenberg is currently ranked #1678 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does David cover?

David most recently has ratings on A, TWST, IT:DIA, FR:BIM, WAT, TMO, TECH, DHR, GRAL, GH, MYGN, CAI and 27 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!